Regulatory Approvals

FDA Approves Generic Lanreotide Injection for GEP-NETs

By

Regulatory Approvals — FDA Approves Generic Lanreotide Injection for GEP-NETs  OncLive

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 22, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs

Regulatory Approvals

Cordis wins FDA approval for sirolimus-eluting balloon

Regulatory Approvals

FDA Approves Lutetium Lu 177 Dotatate for GEP-NET Care

Financial News For All

Labor

Chicago hotel workers authorize strike at 46 hotels

Labor

Powerful New York Labor Group Seeks to Unionize 190,000 Health Workers

Labor

City of Solvang Workers Enter Second Week of Strike

Labor

Prime Healthcare fires, suspends 20 CMMC nurses ahead of union election